泰坦酸石墨烯氧化物纳米复合材料为基础的费城阳性白血病疗法
Maria Batool1, Rida-E-Maria Qazi2, Muhammad Ahmad Mudassir1,3
1Institute of Chemistry, Khwaja Fareed University of Engineering and Information Technology (KFUEIT), Rahim Yar Khan 64200, Pakistan.
ACS applied bio materials
|June 20, 2024
概括
二氧化-石墨烯氧化物纳米复合物有效地为费城阳性白血病治疗提供氨酸激酶抑制剂. 这种纳米技术方法在向癌细胞和降低关键信号通路的调节方面表现有前途,为白血病治疗提供了潜在的进步.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 费城阳性 (Ph+) 白血病,急性淋巴细胞白血病 (ALL) 的一个亚型,在有限的治疗选择和频繁的复发的情况下,提出了重大的治疗挑战.
- 目前的治疗方法,如氨酸激酶抑制剂 (TKIs),往往受到药物耐药性和严重的副作用,特别是心血管并发症的阻碍.
- 纳米技术为向药物输送和控制释放TKI提供了一个有希望的途径,可能克服现有的治疗局限性.
研究的目的:
- 研究二氧化-石墨烯氧化物 (TiO2-GO) 纳米复合物的有效性,用于加载和输送用于Ph+白血病治疗的TKI (尼洛替尼和波纳替尼).
- 评估TKI载荷的TiO2-GO纳米复合物的治疗潜力在白血病细胞系和癌基因表达细胞上.
- 评估TKI载入的TiO2-GO对特定癌症相关细胞信号通路的影响.
主要方法:
- 使用包括SEM,DLS,XRD,FTIR,泽塔潜力,EDX和元素映射在内的技术合成和描述TiO2-GO纳米复合材料.
- 在K562和Ba/F3细胞系上使用细胞活力试验 (XTT),亡诱导和殖民地形成抑制试验进行TCI载荷TiO2-GO疗效的体外评估.
- 西方斑分析用于研究受治疗细胞中mTOR,STAT5和Erk1/2信号通路的调节.
主要成果:
- TiO2-GO纳米复合材料成功合成和表征,证实它们适用于药物加载.
- 装有TKI的TiO2-GO在Ph+白血病模型中,在降低细胞活力,诱导细胞亡和抑制细胞殖民地形成方面,表现出与自由TKI相似的疗效.
- 在用TKI载荷TiO2-GO.治疗的细胞中观察到关键信号通路的显著下调,包括mTOR,STAT5和Erk1/2.
结论:
- TiO2-GO纳米复合材料显示出作为Ph+白血病治疗的药物输送系统的极佳潜力.
- 这种基于纳米技术的方法有效地提供了技术知识,并调节了关键的癌症信号通路.
- 需要进一步的研究来将这些发现转化为治疗Ph+白血病的临床应用.
更多相关视频
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.1K
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
10.3K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
